You are here

ACC

ACC 25: Biocardia’s CardiAMP trial fails but cell therapy potential remains

Clinical Trials Arena

Tue, 04/1/25 - 11:34 am

heart failure with reduced ejection fraction

Medtronic Breaks Out Strong TAVR Data at ACC

Medical Devices and Diagnostics Industry

Mon, 03/31/25 - 11:06 pm

ACC25: Ozempic shows its value in PAD

Pharmaphorum

Mon, 03/31/25 - 10:03 am

type 2 diabetes

Novo’s Wegovy Shows Stronger Weight-Loss Effects in Women Than Men: Study

BioSpace

Mon, 06/24/24 - 11:23 am

Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD

Clinical Trials Arena

Mon, 03/13/23 - 10:03 am

real world data

atrial fibrillation

ACC 2023 – the market tries to take Medtronic’s pulse

EP Vantage

Wed, 03/8/23 - 09:33 am

pulsed field ablation

clinical trials

ACC23: J&J's combo pill of Opsumit plus tadalafil improves blood flow in PAH patients

Fierce Pharma

Mon, 03/6/23 - 10:51 am

ACC 2023 – Esperion’s outcomes win looks lacklustre

EP Vantage

Mon, 03/6/23 - 10:45 am

Esperion Therapeutics

Medtronic self-expanding TAVR shows durability benefit over surgery at 5 years, analysis shows

Medtech Dive

Wed, 04/6/22 - 07:39 pm

ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late

EP Vantage

Tue, 04/5/22 - 10:59 am

Ionis Pharmaceuticals

ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients

Fierce Pharma

Mon, 04/4/22 - 11:20 pm

ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals

Fierce Pharma

Mon, 04/4/22 - 10:59 am

Lexicon Pharmaceuticals

type 2 diabetes

ACC 2022 – Bristol's rare hit could justify Myokardia

EP Vantage

Sat, 04/2/22 - 11:38 am

Bristol Myers Squibb

hypertrophic cardiomyopathy

ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure

Fierce Biotech

Mon, 05/17/21 - 10:48 am

Omecamtiv Mecarbil

Boston Scientific's Watchman shows low stroke rate in large registry at ACC

Medtech Dive

Mon, 05/17/21 - 10:41 am

Boston Scientific

atrial fibrillation

ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients

Fierce Pharma

Sun, 05/16/21 - 11:32 pm

Regeneron's Evkeeza shows promise in curbing high triglycerides, but will genetic disparities limit use?

Endpoints

Sun, 05/16/21 - 11:30 pm

high triclycerides

ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients

Fierce Pharma

Sat, 05/15/21 - 11:00 pm

ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half

Fierce Biotech

Sat, 03/28/20 - 11:43 pm

PCSK9 inhibitors

ACC: Esperion's Nexletol busts cholesterol levels regardless of statin, ezitimibe therapy

Fierce Pharma

Sat, 03/28/20 - 11:37 pm

clinical trials

c-reactive protein

Pages